跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONSTRYV - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ONSTRYV
Authorized
STANDARD
ONSTRYV
Valeo Pharma Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
540ebf7980b1f60d
Company
Valeo Pharma Inc
Type
Standard
Approval Details
Approval Id
540ebf7980b1f60d
Drug Approval Canada Name
ONSTRYV
Product Name
ONSTRYV
Status
Marketed
Status Date
2019-07-08
Original Market Date
2019-07-08
Din
02484641
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:36.32
Atc Original
N04BD03 SAFINAMIDE
Atc Name
n 04 bd 03
Aig Number
0161151001
Company Name
Valeo Pharma Inc
Company Address
16667 Hymus Blvd., Kirkland, Quebec, Canada, H9H 4R9
Active Ingredients
SAFINAMIDE (SAFINAMIDE MESYLATE)
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
540ebf7980b1f60d
Type
Standard
Back to Health Canada Approvals